Company profile: Retia Medical
1.1 - Company Overview
Company description
- Provider of patient monitoring software and hardware, notably the Argos Cardiac Output Monitor using a proprietary Multi-Beat Analysis algorithm for accurate, real-time cardiac output and comprehensive hemodynamic data. Offers quick setup via a single reusable cable, compatibility with arterial lines and multi-parameter monitors, integration with 40+ EMRs, and demonstrated reductions in complications and ICU stay.
Products and services
- Argos Cardiac Output Monitor: A real-time hemodynamic monitor leveraging Multi-Beat Analysis for accurate cardiac output, with comprehensive data, single reusable cable setup, and compatibility with arterial lines and multi-parameter monitors
- Demonstrated Value: An EMR-integrated capability shown to reduce complications and ICU length of stay while delivering operational savings by eliminating per‑patient costs and integrating with over 40 EMR systems
- MBA Algorithm: A proprietary multi‑beat analysis method architected for the Argos Monitor that delivers accurate cardiac output measurements by analyzing multiple heartbeats
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Retia Medical
LifeWatch
HQ: Switzerland
Website
- Description: Provider of remote cardiac monitoring and digital health solutions, offering wireless remote diagnostic patient monitoring services that deliver critical data for treatment decisions. Solutions include Philips Mobile Cardiac Telemetry (MCOT), Philips ePatch Extended Holter, Implantable Device Monitoring, EMR Integration, Telehealth Home Connect for at-home monitor application, and Remote INR patient self-testing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full LifeWatch company profile →
Interrad Medical
HQ: United States
Website
- Description: Provider of innovative medical devices for minimally invasive interventional and surgical procedures, including SecurAcath, a subcutaneous anchoring device that secures peripherally inserted central catheters (PICCs) and other central venous catheters (CVCs), reducing the risk of catheter migration and dislodgement.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Interrad Medical company profile →
HighLife Medical
HQ: France
Website
- Description: Provider of transcatheter mitral valve replacement solutions for patients with mitral valve regurgitation. Offers the HighLife TSMVR Solution, a system designed for moderate to severe mitral regurgitation patients at high surgical risk; technology is currently in clinical evaluation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full HighLife Medical company profile →
Cardio Polymers
HQ: United States
Website
- Description: Provider of biocompatible polymer implant therapies and implantable devices to treat chronic heart failure, mitral valve regurgitation, and postoperative atrial fibrillation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cardio Polymers company profile →
Vdyne
HQ: United States
Website
- Description: Provider of proprietary transcatheter valve technology to treat tricuspid regurgitation via a unique side-delivery method, enabling treatment for a broader patient population; developing tricuspid replacement valve and repair technology.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Vdyne company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Retia Medical
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Retia Medical
2.2 - Growth funds investing in similar companies to Retia Medical
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Retia Medical
4.2 - Public trading comparable groups for Retia Medical
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →